The Food and Drug Administration's medical device approval processwas taken to task this month in a report presented to a congressionalsubcommittee. The report portrayed the FDA's Center for Devices and RadiologicalHealth (CDRH) as plagued by
The Food and Drug Administration's medical device approval processwas taken to task this month in a report presented to a congressionalsubcommittee.
The report portrayed the FDA's Center for Devices and RadiologicalHealth (CDRH) as plagued by inefficient use of resources and apervasive bias in favor of device manufacturers.
The report quotes FDA device reviewers as stating that:
The report was presented to the House of Representatives subcommitteeon oversight and investigations by subcommittee investigator ThomasDorney, who sent confidential questionnaires to FDA device reviewers.
Although many questionnaires are still outstanding, about halfof those that have been returned claim that politics sometimescarries as much weight as science in the device approval process.
"A reviewer who completed the questionnaire (pointed out)the title of the Office of Device Evaluation should be changedto Office of Device Approval," Dorney said.
The chaotic approval process has the effect of penalizing firmswith well-made devices while benefiting companies that aren'tas well prepared or as competent, Dorney said.
FDA representatives at the subcommittee hearing responded byacknowledging that problems exist within the device approval process,but claimed the agency is moving quickly to remedy them. The FDAhas appointed a new ODE director with a strong scientific background,has launched a series of internal audits of the approval processand has appointed an integrity officer.
Reform of the agency's approval process is needed, said subcommitteechairman John Dingell (D-MI). However, any such reform must bedone without "bringing the approval process to a grindinghalt," he said.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.